Recro's Late-Stage IV Meloxicam Trial Results Rocket Stock Skyward
November 28, 2016 at 10:42 AM EST
Recro Pharma Inc (NASDAQ: REPH) shares are jumping on Monday after it announced positive top-line results from the second of the two ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.